The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Physiologically Active Peptides Market Research Report 2025
Synopsis
The global Physiologically Active Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Physiologically Active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Physiologically Active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Physiologically Active Peptides include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Physiologically Active Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Physiologically Active Peptides.
The Physiologically Active Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Physiologically Active Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Physiologically Active Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Merck KGaA
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
by Type
Antimicrobial Peptides
Neuroactive Peptides
Immunoactive Peptides
Antioxidant Peptides
Others
by Application
Food and Beverages
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Physiologically Active Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Physiologically Active Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Physiologically Active Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Physiologically Active Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Physiologically Active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Physiologically Active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Physiologically Active Peptides include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Physiologically Active Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Physiologically Active Peptides.
The Physiologically Active Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Physiologically Active Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Physiologically Active Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Merck KGaA
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
by Type
Antimicrobial Peptides
Neuroactive Peptides
Immunoactive Peptides
Antioxidant Peptides
Others
by Application
Food and Beverages
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Physiologically Active Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Physiologically Active Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Physiologically Active Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Physiologically Active Peptides Market Overview
1.1 Product Definition
1.2 Physiologically Active Peptides by Type
1.2.1 Global Physiologically Active Peptides Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Antimicrobial Peptides
1.2.3 Neuroactive Peptides
1.2.4 Immunoactive Peptides
1.2.5 Antioxidant Peptides
1.2.6 Others
1.3 Physiologically Active Peptides by Application
1.3.1 Global Physiologically Active Peptides Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Food and Beverages
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Physiologically Active Peptides Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Physiologically Active Peptides Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Physiologically Active Peptides Production Estimates and Forecasts (2019-2030)
1.4.4 Global Physiologically Active Peptides Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Physiologically Active Peptides Production Market Share by Manufacturers (2019-2024)
2.2 Global Physiologically Active Peptides Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Physiologically Active Peptides, Industry Ranking, 2022 VS 2023
2.4 Global Physiologically Active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Physiologically Active Peptides Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Physiologically Active Peptides, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Physiologically Active Peptides, Product Offered and Application
2.8 Global Key Manufacturers of Physiologically Active Peptides, Date of Enter into This Industry
2.9 Physiologically Active Peptides Market Competitive Situation and Trends
2.9.1 Physiologically Active Peptides Market Concentration Rate
2.9.2 Global 5 and 10 Largest Physiologically Active Peptides Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Physiologically Active Peptides Production by Region
3.1 Global Physiologically Active Peptides Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Physiologically Active Peptides Production Value by Region (2019-2030)
3.2.1 Global Physiologically Active Peptides Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Physiologically Active Peptides by Region (2025-2030)
3.3 Global Physiologically Active Peptides Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Physiologically Active Peptides Production by Region (2019-2030)
3.4.1 Global Physiologically Active Peptides Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Physiologically Active Peptides by Region (2025-2030)
3.5 Global Physiologically Active Peptides Market Price Analysis by Region (2019-2024)
3.6 Global Physiologically Active Peptides Production and Value, Year-over-Year Growth
3.6.1 North America Physiologically Active Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Physiologically Active Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Physiologically Active Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Physiologically Active Peptides Production Value Estimates and Forecasts (2019-2030)
4 Physiologically Active Peptides Consumption by Region
4.1 Global Physiologically Active Peptides Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Physiologically Active Peptides Consumption by Region (2019-2030)
4.2.1 Global Physiologically Active Peptides Consumption by Region (2019-2030)
4.2.2 Global Physiologically Active Peptides Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Physiologically Active Peptides Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Physiologically Active Peptides Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Physiologically Active Peptides Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Physiologically Active Peptides Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Physiologically Active Peptides Production by Type (2019-2030)
5.1.1 Global Physiologically Active Peptides Production by Type (2019-2024)
5.1.2 Global Physiologically Active Peptides Production by Type (2025-2030)
5.1.3 Global Physiologically Active Peptides Production Market Share by Type (2019-2030)
5.2 Global Physiologically Active Peptides Production Value by Type (2019-2030)
5.2.1 Global Physiologically Active Peptides Production Value by Type (2019-2024)
5.2.2 Global Physiologically Active Peptides Production Value by Type (2025-2030)
5.2.3 Global Physiologically Active Peptides Production Value Market Share by Type (2019-2030)
5.3 Global Physiologically Active Peptides Price by Type (2019-2030)
6 Segment by Application
6.1 Global Physiologically Active Peptides Production by Application (2019-2030)
6.1.1 Global Physiologically Active Peptides Production by Application (2019-2024)
6.1.2 Global Physiologically Active Peptides Production by Application (2025-2030)
6.1.3 Global Physiologically Active Peptides Production Market Share by Application (2019-2030)
6.2 Global Physiologically Active Peptides Production Value by Application (2019-2030)
6.2.1 Global Physiologically Active Peptides Production Value by Application (2019-2024)
6.2.2 Global Physiologically Active Peptides Production Value by Application (2025-2030)
6.2.3 Global Physiologically Active Peptides Production Value Market Share by Application (2019-2030)
6.3 Global Physiologically Active Peptides Price by Application (2019-2030)
7 Key Companies Profiled
7.1 American Peptide Company Inc.
7.1.1 American Peptide Company Inc. Physiologically Active Peptides Company Information
7.1.2 American Peptide Company Inc. Physiologically Active Peptides Product Portfolio
7.1.3 American Peptide Company Inc. Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.1.4 American Peptide Company Inc. Main Business and Markets Served
7.1.5 American Peptide Company Inc. Recent Developments/Updates
7.2 Phermpep Co. Ltd.
7.2.1 Phermpep Co. Ltd. Physiologically Active Peptides Company Information
7.2.2 Phermpep Co. Ltd. Physiologically Active Peptides Product Portfolio
7.2.3 Phermpep Co. Ltd. Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Phermpep Co. Ltd. Main Business and Markets Served
7.2.5 Phermpep Co. Ltd. Recent Developments/Updates
7.3 ALEXIS Corporation
7.3.1 ALEXIS Corporation Physiologically Active Peptides Company Information
7.3.2 ALEXIS Corporation Physiologically Active Peptides Product Portfolio
7.3.3 ALEXIS Corporation Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.3.4 ALEXIS Corporation Main Business and Markets Served
7.3.5 ALEXIS Corporation Recent Developments/Updates
7.4 Merck KGaA
7.4.1 Merck KGaA Physiologically Active Peptides Company Information
7.4.2 Merck KGaA Physiologically Active Peptides Product Portfolio
7.4.3 Merck KGaA Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Merck KGaA Main Business and Markets Served
7.4.5 Merck KGaA Recent Developments/Updates
7.5 Promega Corporation
7.5.1 Promega Corporation Physiologically Active Peptides Company Information
7.5.2 Promega Corporation Physiologically Active Peptides Product Portfolio
7.5.3 Promega Corporation Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Promega Corporation Main Business and Markets Served
7.5.5 Promega Corporation Recent Developments/Updates
7.6 Advanced Bioconcept Company
7.6.1 Advanced Bioconcept Company Physiologically Active Peptides Company Information
7.6.2 Advanced Bioconcept Company Physiologically Active Peptides Product Portfolio
7.6.3 Advanced Bioconcept Company Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Advanced Bioconcept Company Main Business and Markets Served
7.6.5 Advanced Bioconcept Company Recent Developments/Updates
7.7 Arlak Biotech
7.7.1 Arlak Biotech Physiologically Active Peptides Company Information
7.7.2 Arlak Biotech Physiologically Active Peptides Product Portfolio
7.7.3 Arlak Biotech Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Arlak Biotech Main Business and Markets Served
7.7.5 Arlak Biotech Recent Developments/Updates
7.8 WN Pharmaceuticals Ltd.
7.8.1 WN Pharmaceuticals Ltd. Physiologically Active Peptides Company Information
7.8.2 WN Pharmaceuticals Ltd. Physiologically Active Peptides Product Portfolio
7.8.3 WN Pharmaceuticals Ltd. Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.8.4 WN Pharmaceuticals Ltd. Main Business and Markets Served
7.8.5 WN Pharmaceuticals Ltd. Recent Developments/Updates
7.9 Anaspec Inc.
7.9.1 Anaspec Inc. Physiologically Active Peptides Company Information
7.9.2 Anaspec Inc. Physiologically Active Peptides Product Portfolio
7.9.3 Anaspec Inc. Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Anaspec Inc. Main Business and Markets Served
7.9.5 Anaspec Inc. Recent Developments/Updates
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Physiologically Active Peptides Company Information
7.10.2 Thermo Fisher Scientific Physiologically Active Peptides Product Portfolio
7.10.3 Thermo Fisher Scientific Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Thermo Fisher Scientific Main Business and Markets Served
7.10.5 Thermo Fisher Scientific Recent Developments/Updates
7.11 Seagarden AS
7.11.1 Seagarden AS Physiologically Active Peptides Company Information
7.11.2 Seagarden AS Physiologically Active Peptides Product Portfolio
7.11.3 Seagarden AS Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Seagarden AS Main Business and Markets Served
7.11.5 Seagarden AS Recent Developments/Updates
7.12 Novo Nordisk A/S
7.12.1 Novo Nordisk A/S Physiologically Active Peptides Company Information
7.12.2 Novo Nordisk A/S Physiologically Active Peptides Product Portfolio
7.12.3 Novo Nordisk A/S Physiologically Active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Novo Nordisk A/S Main Business and Markets Served
7.12.5 Novo Nordisk A/S Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Physiologically Active Peptides Industry Chain Analysis
8.2 Physiologically Active Peptides Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Physiologically Active Peptides Production Mode & Process
8.4 Physiologically Active Peptides Sales and Marketing
8.4.1 Physiologically Active Peptides Sales Channels
8.4.2 Physiologically Active Peptides Distributors
8.5 Physiologically Active Peptides Customers
9 Physiologically Active Peptides Market Dynamics
9.1 Physiologically Active Peptides Industry Trends
9.2 Physiologically Active Peptides Market Drivers
9.3 Physiologically Active Peptides Market Challenges
9.4 Physiologically Active Peptides Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Physiologically Active Peptides Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Physiologically Active Peptides Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Physiologically Active Peptides Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Physiologically Active Peptides Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Physiologically Active Peptides Production Market Share by Manufacturers (2019-2024)
Table 6. Global Physiologically Active Peptides Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Physiologically Active Peptides Production Value Share by Manufacturers (2019-2024)
Table 8. Global Key Players of Physiologically Active Peptides, Industry Ranking, 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Physiologically Active Peptides as of 2023)
Table 10. Global Market Physiologically Active Peptides Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Global Key Manufacturers of Physiologically Active Peptides, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Physiologically Active Peptides, Product Offered and Application
Table 13. Global Key Manufacturers of Physiologically Active Peptides, Date of Enter into This Industry
Table 14. Global Physiologically Active Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Physiologically Active Peptides Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Physiologically Active Peptides Production Value (US$ Million) by Region (2019-2024)
Table 18. Global Physiologically Active Peptides Production Value Market Share by Region (2019-2024)
Table 19. Global Physiologically Active Peptides Production Value (US$ Million) Forecast by Region (2025-2030)
Table 20. Global Physiologically Active Peptides Production Value Market Share Forecast by Region (2025-2030)
Table 21. Global Physiologically Active Peptides Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Physiologically Active Peptides Production (Tons) by Region (2019-2024)
Table 23. Global Physiologically Active Peptides Production Market Share by Region (2019-2024)
Table 24. Global Physiologically Active Peptides Production (Tons) Forecast by Region (2025-2030)
Table 25. Global Physiologically Active Peptides Production Market Share Forecast by Region (2025-2030)
Table 26. Global Physiologically Active Peptides Market Average Price (US$/Ton) by Region (2019-2024)
Table 27. Global Physiologically Active Peptides Market Average Price (US$/Ton) by Region (2025-2030)
Table 28. Global Physiologically Active Peptides Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 29. Global Physiologically Active Peptides Consumption by Region (2019-2024) & (Tons)
Table 30. Global Physiologically Active Peptides Consumption Market Share by Region (2019-2024)
Table 31. Global Physiologically Active Peptides Forecasted Consumption by Region (2025-2030) & (Tons)
Table 32. Global Physiologically Active Peptides Forecasted Consumption Market Share by Region (2019-2024)
Table 33. North America Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 34. North America Physiologically Active Peptides Consumption by Country (2019-2024) & (Tons)
Table 35. North America Physiologically Active Peptides Consumption by Country (2025-2030) & (Tons)
Table 36. Europe Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 37. Europe Physiologically Active Peptides Consumption by Country (2019-2024) & (Tons)
Table 38. Europe Physiologically Active Peptides Consumption by Country (2025-2030) & (Tons)
Table 39. Asia Pacific Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 40. Asia Pacific Physiologically Active Peptides Consumption by Region (2019-2024) & (Tons)
Table 41. Asia Pacific Physiologically Active Peptides Consumption by Region (2025-2030) & (Tons)
Table 42. Latin America, Middle East & Africa Physiologically Active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 43. Latin America, Middle East & Africa Physiologically Active Peptides Consumption by Country (2019-2024) & (Tons)
Table 44. Latin America, Middle East & Africa Physiologically Active Peptides Consumption by Country (2025-2030) & (Tons)
Table 45. Global Physiologically Active Peptides Production (Tons) by Type (2019-2024)
Table 46. Global Physiologically Active Peptides Production (Tons) by Type (2025-2030)
Table 47. Global Physiologically Active Peptides Production Market Share by Type (2019-2024)
Table 48. Global Physiologically Active Peptides Production Market Share by Type (2025-2030)
Table 49. Global Physiologically Active Peptides Production Value (US$ Million) by Type (2019-2024)
Table 50. Global Physiologically Active Peptides Production Value (US$ Million) by Type (2025-2030)
Table 51. Global Physiologically Active Peptides Production Value Market Share by Type (2019-2024)
Table 52. Global Physiologically Active Peptides Production Value Market Share by Type (2025-2030)
Table 53. Global Physiologically Active Peptides Price (US$/Ton) by Type (2019-2024)
Table 54. Global Physiologically Active Peptides Price (US$/Ton) by Type (2025-2030)
Table 55. Global Physiologically Active Peptides Production (Tons) by Application (2019-2024)
Table 56. Global Physiologically Active Peptides Production (Tons) by Application (2025-2030)
Table 57. Global Physiologically Active Peptides Production Market Share by Application (2019-2024)
Table 58. Global Physiologically Active Peptides Production Market Share by Application (2025-2030)
Table 59. Global Physiologically Active Peptides Production Value (US$ Million) by Application (2019-2024)
Table 60. Global Physiologically Active Peptides Production Value (US$ Million) by Application (2025-2030)
Table 61. Global Physiologically Active Peptides Production Value Market Share by Application (2019-2024)
Table 62. Global Physiologically Active Peptides Production Value Market Share by Application (2025-2030)
Table 63. Global Physiologically Active Peptides Price (US$/Ton) by Application (2019-2024)
Table 64. Global Physiologically Active Peptides Price (US$/Ton) by Application (2025-2030)
Table 65. American Peptide Company Inc. Physiologically Active Peptides Company Information
Table 66. American Peptide Company Inc. Physiologically Active Peptides Specification and Application
Table 67. American Peptide Company Inc. Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 68. American Peptide Company Inc. Main Business and Markets Served
Table 69. American Peptide Company Inc. Recent Developments/Updates
Table 70. Phermpep Co. Ltd. Physiologically Active Peptides Company Information
Table 71. Phermpep Co. Ltd. Physiologically Active Peptides Specification and Application
Table 72. Phermpep Co. Ltd. Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Phermpep Co. Ltd. Main Business and Markets Served
Table 74. Phermpep Co. Ltd. Recent Developments/Updates
Table 75. ALEXIS Corporation Physiologically Active Peptides Company Information
Table 76. ALEXIS Corporation Physiologically Active Peptides Specification and Application
Table 77. ALEXIS Corporation Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. ALEXIS Corporation Main Business and Markets Served
Table 79. ALEXIS Corporation Recent Developments/Updates
Table 80. Merck KGaA Physiologically Active Peptides Company Information
Table 81. Merck KGaA Physiologically Active Peptides Specification and Application
Table 82. Merck KGaA Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Merck KGaA Main Business and Markets Served
Table 84. Merck KGaA Recent Developments/Updates
Table 85. Promega Corporation Physiologically Active Peptides Company Information
Table 86. Promega Corporation Physiologically Active Peptides Specification and Application
Table 87. Promega Corporation Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Promega Corporation Main Business and Markets Served
Table 89. Promega Corporation Recent Developments/Updates
Table 90. Advanced Bioconcept Company Physiologically Active Peptides Company Information
Table 91. Advanced Bioconcept Company Physiologically Active Peptides Specification and Application
Table 92. Advanced Bioconcept Company Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Advanced Bioconcept Company Main Business and Markets Served
Table 94. Advanced Bioconcept Company Recent Developments/Updates
Table 95. Arlak Biotech Physiologically Active Peptides Company Information
Table 96. Arlak Biotech Physiologically Active Peptides Specification and Application
Table 97. Arlak Biotech Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Arlak Biotech Main Business and Markets Served
Table 99. Arlak Biotech Recent Developments/Updates
Table 100. WN Pharmaceuticals Ltd. Physiologically Active Peptides Company Information
Table 101. WN Pharmaceuticals Ltd. Physiologically Active Peptides Specification and Application
Table 102. WN Pharmaceuticals Ltd. Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. WN Pharmaceuticals Ltd. Main Business and Markets Served
Table 104. WN Pharmaceuticals Ltd. Recent Developments/Updates
Table 105. Anaspec Inc. Physiologically Active Peptides Company Information
Table 106. Anaspec Inc. Physiologically Active Peptides Specification and Application
Table 107. Anaspec Inc. Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Anaspec Inc. Main Business and Markets Served
Table 109. Anaspec Inc. Recent Developments/Updates
Table 110. Thermo Fisher Scientific Physiologically Active Peptides Company Information
Table 111. Thermo Fisher Scientific Physiologically Active Peptides Specification and Application
Table 112. Thermo Fisher Scientific Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Thermo Fisher Scientific Main Business and Markets Served
Table 114. Thermo Fisher Scientific Recent Developments/Updates
Table 115. Seagarden AS Physiologically Active Peptides Company Information
Table 116. Seagarden AS Physiologically Active Peptides Specification and Application
Table 117. Seagarden AS Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Seagarden AS Main Business and Markets Served
Table 119. Seagarden AS Recent Developments/Updates
Table 120. Novo Nordisk A/S Physiologically Active Peptides Company Information
Table 121. Novo Nordisk A/S Physiologically Active Peptides Specification and Application
Table 122. Novo Nordisk A/S Physiologically Active Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Novo Nordisk A/S Main Business and Markets Served
Table 124. Novo Nordisk A/S Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Physiologically Active Peptides Distributors List
Table 128. Physiologically Active Peptides Customers List
Table 129. Physiologically Active Peptides Market Trends
Table 130. Physiologically Active Peptides Market Drivers
Table 131. Physiologically Active Peptides Market Challenges
Table 132. Physiologically Active Peptides Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Physiologically Active Peptides
Figure 2. Global Physiologically Active Peptides Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Physiologically Active Peptides Market Share by Type: 2023 VS 2030
Figure 4. Antimicrobial Peptides Product Picture
Figure 5. Neuroactive Peptides Product Picture
Figure 6. Immunoactive Peptides Product Picture
Figure 7. Antioxidant Peptides Product Picture
Figure 8. Others Product Picture
Figure 9. Global Physiologically Active Peptides Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 10. Global Physiologically Active Peptides Market Share by Application: 2023 VS 2030
Figure 11. Food and Beverages
Figure 12. Cosmetics
Figure 13. Others
Figure 14. Global Physiologically Active Peptides Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Physiologically Active Peptides Production Value (US$ Million) & (2019-2030)
Figure 16. Global Physiologically Active Peptides Production Capacity (Tons) & (2019-2030)
Figure 17. Global Physiologically Active Peptides Production (Tons) & (2019-2030)
Figure 18. Global Physiologically Active Peptides Average Price (US$/Ton) & (2019-2030)
Figure 19. Physiologically Active Peptides Report Years Considered
Figure 20. Physiologically Active Peptides Production Share by Manufacturers in 2023
Figure 21. Physiologically Active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. The Global 5 and 10 Largest Players: Market Share by Physiologically Active Peptides Revenue in 2023
Figure 23. Global Physiologically Active Peptides Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 24. Global Physiologically Active Peptides Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 25. Global Physiologically Active Peptides Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 26. Global Physiologically Active Peptides Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. North America Physiologically Active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Europe Physiologically Active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. China Physiologically Active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 30. Japan Physiologically Active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 31. Global Physiologically Active Peptides Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 32. Global Physiologically Active Peptides Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 33. North America Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 34. North America Physiologically Active Peptides Consumption Market Share by Country (2019-2030)
Figure 35. U.S. Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 36. Canada Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 37. Europe Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 38. Europe Physiologically Active Peptides Consumption Market Share by Country (2019-2030)
Figure 39. Germany Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 40. France Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 41. U.K. Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 42. Italy Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 43. Russia Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 44. Asia Pacific Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 45. Asia Pacific Physiologically Active Peptides Consumption Market Share by Region (2025-2030)
Figure 46. China Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 47. Japan Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 48. South Korea Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 49. China Taiwan Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 50. Southeast Asia Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 51. India Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 52. Latin America, Middle East & Africa Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 53. Latin America, Middle East & Africa Physiologically Active Peptides Consumption Market Share by Country (2019-2030)
Figure 54. Mexico Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 55. Brazil Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 56. Turkey Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 57. GCC Countries Physiologically Active Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 58. Global Production Market Share of Physiologically Active Peptides by Type (2019-2030)
Figure 59. Global Production Value Market Share of Physiologically Active Peptides by Type (2019-2030)
Figure 60. Global Physiologically Active Peptides Price (US$/Ton) by Type (2019-2030)
Figure 61. Global Production Market Share of Physiologically Active Peptides by Application (2019-2030)
Figure 62. Global Production Value Market Share of Physiologically Active Peptides by Application (2019-2030)
Figure 63. Global Physiologically Active Peptides Price (US$/Ton) by Application (2019-2030)
Figure 64. Physiologically Active Peptides Value Chain
Figure 65. Physiologically Active Peptides Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
